← Today’s ReceiptsOfficial public filing linked
Public-record receiptR-NCOfficial filing linked
Virginia Foxx disclosed SELL $BMY
Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.
Trade range
$1K – $15K
Filed
2025-07-01
Trade date
2025-06-24
Disclosure lag
7 days after trade
Why this receipt matters
A quick read before you share it.
These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.
1The receipt links to an official public filing, so readers can verify the underlying disclosure before sharing.
2The filing appeared 7 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $1K – $15K, which is the public reporting band rather than an exact profit or loss figure.
44 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Virginia Foxx, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 10 lobbying filings.
Source
Official filing ↗
Source: official House/Senate financial disclosure record · filing ID 20030587 · filed 2025-07-01 · disclosed 7d after transaction
Market context
Bristol-Myers Squibb Company
Sector: Healthcare
Factual flags
- 10 lobbying filings linked to this ticker.
- 4 nearby same-ticker disclosures in the surrounding 30-day window.
- 4 trades filed on 2025-07-01 (batch dump)
Member trail
Virginia Foxx
U.S. House · NC-5
House Committee on Oversight and Government ReformHouse Committee on Education and WorkforceHouse Committee on Rules
Ticker trail
$BMY
Bristol-Myers Squibb Company
Follow this tickerAlert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.